Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

GSK initiates phase I study of S. aureus vaccine candidate GSK-3878858-A

July 20, 2020

Synairgen reports promising data from SNG-001 trial in hospitalized COVID-19 patients

July 20, 2020

Positive preclinical results reported for LineaDNA COVID-19 vaccine candidates

July 20, 2020

Carragelose shows efficacy against SARS-CoV-2 in cell culture assays

July 20, 2020

Centivax antibody shows potential as therapeutic and prophylactic in models of COVID-19

July 20, 2020

Biotest submits phase II study of trimodulin for severe COVID-19 in Spain

July 20, 2020

Celltrion advances antiviral antibody treatment for COVID-19 into phase I

July 17, 2020

Xenleta approved in Canada for community-acquired pneumonia

July 17, 2020

Phase III trial begins in UAE for Sinopharm's inactivated vaccine for COVID-19

July 17, 2020

Dynavax and Mount Sinai collaborate to develop a universal influenza vaccine

July 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...